What sets Trabecular Titanium apart, and why is it a game-changer for patients?
Originally developed to meet surgeons' need for strong primary fixation and to overcome the geometrical limitations of traditional materials, today TT stands out for its unique combination of pioneering heritage, evolving innovation, and unparalleled versatility in orthopedics. Its long-established leadership in 3D printing provides you, our surgeons, with confidence in a technology backed by a proven track record and deep expertise that has earned the trust of the orthopedic community.
What is TT?
Trabecular Titanium (TT) is Enovis' proprietary 3D-printed technology, tailored to produce a highly porous biomaterial, that consistently offers reliable fixation, enhanced biological features, and proven performance. Through collaboration, advanced research, and continuous development, TT continues to shape the next generation of implant design.
With a portfolio that spans standard to fully customized implants, across both primary and revision procedures and for all major joints, TT empowers you, our partners, to address diverse patient needs with confidence, helping deliver consistent, reliable outcomes.
For your patients, this means more personalized solutions, consistent outcomes, and care supported by TT technology with both a trusted past and a forward-looking future.
Together with you, we are committed to restoring motion for life and with Trabecular Titanium, we’re delivering smart, personalized, and effective care for patients, shaping the future of orthopedics.
NEXT ARTICLES
Let’s create better together.
If you have a strong desire to make a difference in the lives of healthcare professionals, their patients, and the communities where we work, explore career opportunities at Enovis.